SCHEMBL8273115

SCHEMBL8273115

COc1ccc2c(OC)ncc(OC)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALDH1A1 P00352 4/20 0.43
CYP3A4 P08684 1/20 0.43
ACHE P22303 1/20 0.41
CHUK O15111 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
GFER P55789 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
THRB P10828 1/20 0.39
CYP1A1 P04798 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13409361 0.85 TRPM8 (0.41) CA12CA1CA2CA7CA9
SCHEMBL14306385 0.81 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL8271703 0.81 PLAU (0.45) ALDH1A1CYP3A4ACHECHUKMEN1
SCHEMBL13729781 0.81 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL13757322 0.81 ACHE (0.41) ALDH1A1CYP3A4ACHECHUKMEN1
SCHEMBL1536565 0.81 DYRK1A (0.43) CA12CA1CA2CA7CA9
SCHEMBL24916397 0.79 P2RX3 (0.42) ALDH1A1CYP3A4ACHECHUKMEN1
SCHEMBL15178715 0.79 ACHE (0.41) ALDH1A1CYP3A4ACHECHUKMEN1
SCHEMBL26262829 0.78 MAP4K1 (0.40) CA1CA2ALDH1A1ACHECHUK
SCHEMBL13757618 0.78 KMT2A (0.45) CYP3A4MEN1KMT2AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012173983-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-12-20 WO disclosed
EP-1505963-B9 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-21 EP disclosed
EP-1505963-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-04-20 EP disclosed
WO-2006000085-A1 HEPATITIS C INHIBITOR PEPTIDE ANALOGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-01-05 WO disclosed